Treatable

Benralizumab

Interleukin-5 Receptor alpha-directed Cytolytic Antibody

Brands

Benralizumab may treat:

Benralizumab contraindicated conditions:

Benralizumab drug classes:

  • Interleukin-5 Receptor alpha-directed Cytolytic Antibody

Benralizumab pharmacologic actions:

  • Anti-Asthmatic Agents

Benralizumab mechanism of action:

  • Interleukin 5 Receptor alpha-directed Antibody Interactions
  • treatable

Copyright © Treatable 2021
Last updated: 9/25/2021, 8:28:25 AM